ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CNSP CNS Pharmaceuticals Inc

0.392
0.022 (5.95%)
Mar 28 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 182,004
Bid Price 0.363
Ask Price 0.393
News -
Day High 0.39

Low
0.229

52 Week Range

High
4.40

Day Low 0.3566
Company Name Stock Ticker Symbol Market Type
CNS Pharmaceuticals Inc CNSP NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.022 5.95% 0.392 19:58:04
Open Price Low Price High Price Close Price Prev Close
0.37 0.3566 0.39 0.362 0.37
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
352 182,004 $ 0.3717916 $ 67,668 - 0.229 - 4.40
Last Trade Time Type Quantity Stock Price Currency
19:30:24 formt 154 $ 0.392 USD

CNS Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.99M 5.25M - 0 -15.27M -2.91 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

CNS Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CNSP Message Board. Create One! See More Posts on CNSP Message Board See More Message Board Posts

Historical CNSP Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.36980.390.3390.371073382,2160.02226.00%
1 Month0.27790.4780.270.3818881309,1140.114141.06%
3 Months1.141.220.2290.3426934427,770-0.748-65.61%
6 Months1.072.750.2290.6361601253,015-0.678-63.36%
1 Year1.054.400.2292.101,093,870-0.658-62.67%
3 Years70.8080.400.22911.66680,649-70.41-99.45%
5 Years123.30170.6970.22932.38652,875-122.91-99.68%

CNS Pharmaceuticals Description

CNS Pharmaceuticals Inc is a preclinical stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma.

Your Recent History

Delayed Upgrade Clock